PubMed COVID-19 Clinical Care

BACKGROUND: The effects of the COVID-19 pandemic have been more pronounced for socially disadvantaged populations. We sought to determine how access to SARS-CoV-2 testing and the likelihood of testing positive for COVID-19 were associated with

CONCLUSIONS: Although harboring a chronic disease, we observed a low SARS-CoV-2 incidence in a cohort of pediatric tertiary care patients, comparable with healthy children during the first year of the pandemic. Infection was mostly associated with

No abstract

The COVID-19 shutdown has caused a quasi-experimental situation for ecologists in Spring 2020, providing an unprecedented release in acoustic space for avian soundscapes due to the lowest technophony levels experienced for decades. We conducted large

CONCLUSIONS: Reductions in virus and particle concentrations were observed on the inside of the face shield; however, viable virus was measured on the inside of the face shield, in the breathing zone of the HCP. Therefore, other exposure control

CONCLUSIONS: Baricitinib treatment was associated with more favorable respiratory improvement at day 7 when compared with tocilizumab, but no differences were observed up to day 28.

No abstract

[This corrects the article DOI: 10.2196/42717.].

Creutzfeldt-Jakob Disease (CJD) is a rare, rapidly progressive, and fatal neurodegenerative disorder. We describe a man whose initial manifestations of CJD occurred shortly after contracting Coronavirus disease 2019 (COVID-19). He first developed

CONCLUSIONS: Surge testing in Bedford reached a large number of people, was particularly successful at reaching people living in the most deprived areas, and identified cases that might have otherwise been missed. However, the testing did not reach